Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Earnings
Pharma
AbbVie touts robust Q3 as analysts query growth past immunology
AbbVie laid out a strong Q3 performance as analysts inquired after growth opportunities, potentially beyond immunology, in the coming decade.
Donavyn Coffey
Oct 30, 2026 3:15pm
Amid Dupixent boom, Sanofi looks hard at its R&D future
Oct 30, 2026 11:50am
AstraZeneca launches $1.5B savings plan to fuel pipeline growth
Oct 30, 2026 10:46am
Lilly lifts guidance on back of another lucrative GLP-1 quarter
Oct 29, 2026 3:31pm
BMS' Cobenfy underwhelms expectations in Q3 report
Oct 29, 2026 11:35am
For Merck, 2027 is ‘another year of investment’
Oct 29, 2026 11:23am
